Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Kashihara

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Clinical and Experimental Nephrology|February 20, 2025
Efficacy and safety of patiromer for hyperkalemia: a randomized, placebo-controlled phase 3 studyNaoki Kashihara, Hirokazu Okada, Yusuke Suzuki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 28, 2010
Erythropoietin enhances hydrogen peroxide-mediated dilatation of canine coronary collateral arterioles during myocardial ischemia in dogs in vivoToyotaka Yada, Hiroaki Shimokawa, Osamu Hiramatsu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2008
Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathyMinoru Satoh, Sohachi Fujimoto, Sayaka Arakawa, et al.
Clinical and Experimental Nephrology|October 24, 2020
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemiaNaoki Kashihara, Yoshimitsu Yamasaki, Takeshi Osonoi, et al.
Clinical and Experimental Nephrology|November 24, 2024
Efficacy and safety of patiromer for non-dialysis and dialysis patients with hyperkalemia: the randomized, placebo-controlled and long-term studyNaoki Kashihara, Yasuro Kumeda, Yorihiko Higashino, et al.
Clinical and Experimental Nephrology|November 13, 2021
Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in JapanKeiichi Matsuzaki, Ryousuke Aoki, Yoshihito Nihei, et al.
Cardiovascular Drugs and Therapy|June 4, 2011
Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuriaKatsuyuki Ando, Masakazu Haneda, Sadayoshi Ito, et al.
Biochemical and Biophysical Research Communications|March 1, 2011
Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signalsHajime Nagasu, Minoru Satoh, Atsunori Kuwabara, et al.
American Journal of Physiology. Renal Physiology|October 30, 2003
Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney modelNaoko Hashimoto, Yohei Maeshima, Minoru Satoh, et al.
Diseases (Basel, Switzerland)|November 26, 2024
The Change in Public Perception and Knowledge Acquisition Methods of Chronic Kidney Disease Among General Population in Okayama Prefecture, JapanRyoko Umebayashi, Natsumi Matsuoka-Uchiyama, Hitoshi Sugiyama, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Clinical and Experimental Nephrology|February 20, 2025
Efficacy and safety of patiromer for hyperkalemia: a randomized, placebo-controlled phase 3 studyNaoki Kashihara, Hirokazu Okada, Yusuke Suzuki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 28, 2010
Erythropoietin enhances hydrogen peroxide-mediated dilatation of canine coronary collateral arterioles during myocardial ischemia in dogs in vivoToyotaka Yada, Hiroaki Shimokawa, Osamu Hiramatsu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2008
Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathyMinoru Satoh, Sohachi Fujimoto, Sayaka Arakawa, et al.
Clinical and Experimental Nephrology|October 24, 2020
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemiaNaoki Kashihara, Yoshimitsu Yamasaki, Takeshi Osonoi, et al.
Clinical and Experimental Nephrology|November 24, 2024
Efficacy and safety of patiromer for non-dialysis and dialysis patients with hyperkalemia: the randomized, placebo-controlled and long-term studyNaoki Kashihara, Yasuro Kumeda, Yorihiko Higashino, et al.
Clinical and Experimental Nephrology|November 13, 2021
Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in JapanKeiichi Matsuzaki, Ryousuke Aoki, Yoshihito Nihei, et al.
Cardiovascular Drugs and Therapy|June 4, 2011
Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuriaKatsuyuki Ando, Masakazu Haneda, Sadayoshi Ito, et al.
Biochemical and Biophysical Research Communications|March 1, 2011
Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signalsHajime Nagasu, Minoru Satoh, Atsunori Kuwabara, et al.
American Journal of Physiology. Renal Physiology|October 30, 2003
Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney modelNaoko Hashimoto, Yohei Maeshima, Minoru Satoh, et al.
Diseases (Basel, Switzerland)|November 26, 2024
The Change in Public Perception and Knowledge Acquisition Methods of Chronic Kidney Disease Among General Population in Okayama Prefecture, JapanRyoko Umebayashi, Natsumi Matsuoka-Uchiyama, Hitoshi Sugiyama, et al.
Pageof 21